While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up......
500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously......
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is......
The production of Covaxin will increase from the current 10 million doses per month to 60 million-70 million by July-August.Sohini Das reports. IMAGE: People wait to get a shot of the COVID-19......
India's Biotech CompaniesWhich was India's first biotech company?Take the Rediff Biz Quiz and find out how much you know about India and its biotech firms.1. Last year, what was the turnover of......